Sign up to see all 4.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Alzamend Neuro Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
KC
Kingsbury Capital Investment Advisors LLC
|
1.3M | 27.54% | +762.4K (+134.5%) | Q1 '26 | 1.4% | |
|
Shares held by quarter
Peak holding1.3M (Q2'26)
Change over 8 quarters+1.3M
Share of the company27.540%
|
||||||
|
KW
KMT Wealth Management, LLC
|
1.3M | 27.54% | NEW | Q2 '26 | 1.4% | |
|
Shares held by quarter
Peak holding1.3M (Q2'26)
Change over 8 quarters+1.3M
Share of the company27.540%
|
||||||
13 more super investors behind a free account
See every manager holding Alzamend Neuro Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FE
Fidelity Concord Street Trust
|
$31.6K | 19.9K | 0.41% | 0.00% | August 31, 2026 |
|
VE
Vanguard Index Funds
|
$9.07K | 7.6K | 0.16% | 0.00% | June 30, 2026 |
2 more funds behind a free account
See every fund holding Alzamend Neuro Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
MC
Milton C. Ault, III
5%+ holder
13D · 4.4%
|
166.9K | 3.46% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
HD
Hyperscale Data, Inc.
5%+ holder
13D · 4.0%
|
153.9K | 3.19% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
5 more holders behind a free account
See every insider and 5%+ holder of Alzamend Neuro Inc.
Sign up freeLoading...